Inclusion Criteria:

• * Subjects with active axillary hidradenitis suppurativa of the same severity bilaterally. regimen
• * For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation
• * Agreement to forego other treatments for hidradenitis for the duration of the study

Exclusion Criteria:

• * Current use of antibiotics, hormonal therapies, steroids, and/or biologics
• * Presence of cardiac pacemaker
• * Pregnancy or lactation
• * Known neuromuscular disorder
• * Known hyperhidrosis
• * Febrile illness within one month
• * Treatment with another investigational drug or other intervention within three months
• * Patients without active axillary hidradenitis suppurativa